Search results
FDA approves AstraZeneca’s Farxiga for paediatric T2D patients
Pharmaceutical Technology via Yahoo Finance· 1 day agoThe US Food and Drug Administration (FDA) has granted approval for AstraZeneca's Farxiga...
AstraZeneca's Farxiga Approved For Treating Pediatric Type-2 Diabetes in U.S.
Market Watch· 2 days agoPublished: June 12, 2024 at 6:01 p.m. ETShareResizeBy Ben GlickmanAstraZeneca's diabetes drug Farxiga on Wednesday was approved by U.S. regulators for the treatment of type-2 diabetes in children ...
Insmed retains rights to brensocatib after talks with AstraZeneca end By Investing.com
Investing.com· 21 hours agoInsmed (NASDAQ:INSM) Incorporated, a pharmaceutical company based in Bridgewater, New Jersey,...
AstraZeneca (LON:AZN) Given New £150 Price Target at Berenberg Bank
ETF DAILY NEWS· 4 days agoAstraZeneca (LON:AZN – Get Free Report) had its target price increased by equities research analysts at Berenberg Bank from £130 ($166.56) to £150 ($192.18) in a research ...
AstraZeneca champions early kidney disease diagnosis with modelling data
Pharmaceutical Technology via Yahoo Finance· 2 days agoAstraZeneca has highlighted both the economic and environmental benefits of implementing early,...
Astrazeneca (AZN) Advances But Underperforms Market: Key Facts
Zacks via Yahoo Finance· 4 days agoAstrazeneca (AZN) closed the most recent trading day at $80.21, moving +0.24% from the previous...
AstraZeneca's (AZN) Tagrisso sNDA Gets FDA's Priority Tag
Zacks via Yahoo Finance· 4 days agoThe FDA grants priority review to AstraZeneca's (AZN) Tagrisso for treating patients with...
AstraZeneca's Farxiga Approved For Treating Pediatric Type-2 Diabetes in U.S.
Morningstar· 2 days agoAstraZeneca's diabetes drug Farxiga on Wednesday was approved by U.S. regulators for the treatment of type-2 diabetes in children 10 and older. Farxiga, which goes by generic ...
Brokerage maintains buy on AstraZeneca shares, sees growth potential By Investing.com
Investing.com· 7 days agoOn Friday, TD Cowen affirmed its positive stance on AstraZeneca (NASDAQ:AZN), maintaining a Buy...
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
Zacks via Yahoo Finance· 2 days agoWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the...